SKI Market

Indian Indices

Sensex

77,566.16 -1,352.74
( -1.71%)

Global Indices

Nasdaq

47,737.88 215.33
(0.45%)

Dow Jones

6,814.47 53.45
(0.79%)

Hang Seng

52,808.52 -2,812.32
(-5.06%)

Nikkei 225

10,249.54 -35.21
(-0.34%)

Forex

USD-INR

91.74 -0.39
(-0.42%)

EUR-INR

106.47 -0.59
(-0.55%)

GBP-INR

122.42 -0.61
(-0.50%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivimed Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532660

INE526G01021

0.9167078

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIVIMEDLAB

56.22

EPS(TTM)

Face Value()

Div & Yield %

Back

Board of Tube Investments of India recommends Interim Dividend

Feb 04,2026

Tube Investments of India announced that the Board of Directors of the Company at its meeting held on 04 February 2026, has recommended a Interim Dividend of Rs.2 per share (i.e.200%), subject to the approval of the shareholders.

77,566.16 -1,352.74 ( -1.71%)

47,737.88 215.33 (0.45%)

6,814.47 53.45 (0.79%)

52,808.52 -2,812.32 (-5.06%)

10,249.54 -35.21 (-0.34%)

91.74 -0.39 (-0.42%)

106.47 -0.59 (-0.55%)

122.42 -0.61 (-0.50%)

0.58 0.00 (-0.46%)